|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Som PM: Detection of metastasis in
cervical lymph nodes: CT and MR criteria and differential
diagnosis. AJR Am J Roentgenol. 158:961–969. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muller S, Su L, Tighiouart M, et al:
Distinctive E-cadherin and epidermal growth factor receptor
expression in metastatic and nonmetastatic head and neck squamous
cell carcinoma: predictive and prognostic correlation. Cancer.
113:97–107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dearth RK, Cui X, Kim HJ, Hadsell DL and
Lee AV: Oncogenic transformation by the signaling adaptor proteins
insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle.
6:705–713. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Metz HE and Houghton AM: Insulin receptor
substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res.
17:206–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang Q, Li Y, White MF, Fletcher JA and
Xiao S: Constitutive activation of insulin receptor substrate 1 is
a frequent event in human tumors: therapeutic implications. Cancer
Res. 62:6035–6038. 2002.
|
|
7
|
Houghton AM, Rzymkiewicz DM, Ji H, et al:
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung
tumor growth. Nat Med. 16:219–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koda M, Sulkowska M, Kanczuga-Koda L and
Sulkowski S: Expression of insulin receptor substrate 1 in primary
breast cancer and lymph node metastases. J Clin Pathol. 58:645–649.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dearth RK, Cui X, Kim HJ, et al: Mammary
tumorigenesis and metastasis caused by overexpression of insulin
receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol. 26:9302–9314.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma Z, Gibson SL, Byrne MA, Zhang J, White
MF and Shaw LM: Suppression of insulin receptor substrate 1 (IRS-1)
promotes mammary tumor metastasis. Mol Cell Biol. 26:9338–9351.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi J, Wang DM, Wang CM, et al: Insulin
receptor substrate-1 suppresses transforming growth
factor-beta1-mediated epithelial-mesenchymal transition. Cancer
Res. 69:7180–7187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vernon AE and LaBonne C: Tumor metastasis:
a new twist on epithelial-mesenchymal transitions. Curr Biol.
14:R719–R721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martin A and Cano A: Tumorigenesis: Twist1
links EMT to self-renewal. Nat Cell Biol. 12:924–925. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McCarthy N: Metastasis: Twisting BMI1. Nat
Rev Cancer. 10:6662010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ventura A and Jacks T: MicroRNAs and
cancer: short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs--the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
21
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO Rep.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wellner U, Schubert J, Burk UC, et al: The
EMT-activator ZEB1 promotes tumorigenicity by repressing
stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang X, Su L, Pirani AA, et al:
Understanding metastatic SCCHN cells from unique genotypes to
phenotypes with the aid of an animal model and DNA microarray
analysis. Clin Exp Metastasis. 23:209–222. 2006. View Article : Google Scholar
|
|
24
|
Zhang X, Liu Y, Gilcrease MZ, et al: A
lymph node metastatic mouse model reveals alterations of
metastasis-related gene expression in metastatic human oral
carcinoma sublines selected from a poorly metastatic parental cell
line. Cancer. 95:1663–1672. 2002. View Article : Google Scholar
|
|
25
|
Zhang H, Su L, Muller S, et al:
Restoration of caveolin-1 expression suppresses growth and
metastasis of head and neck squamous cell carcinoma. Br J Cancer.
99:1684–1694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cantarini MC, de la Monte SM, Pang M, et
al: Aspartyl-asparagyl beta hydroxylase over-expression in human
hepatoma is linked to activation of insulin-like growth factor and
notch signaling mechanisms. Hepatology. 44:446–457. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bazzoni F, Rossato M, Fabbri M, et al:
Induction and regulatory function of miR-9 in human monocytes and
neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci
USA. 106:5282–5287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dubrovska A, Kim S, Salamone RJ, et al:
The role of PTEN/Akt/PI3K signaling in the maintenance and
viability of prostate cancer stem-like cell populations. Proc Natl
Acad Sci USA. 106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tiede S, Kloepper JE, Ernst N, Poeggeler
B, Kruse C and Paus R: Nestin in human skin: exclusive expression
in intramesenchymal skin compartments and regulation by leptin. J
Invest Dermatol. 129:2711–2720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shao M, Cao L, Shen C, et al:
Epithelial-to-mesenchymal transition and ovarian tumor progression
induced by tissue transglutaminase. Cancer Res. 69:9192–9201. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsuji S, Hisaoka M, Morimitsu Y, et al:
Detection of SYT-SSX fusion transcripts in synovial sarcoma by
reverse transcription-polymerase chain reaction using archival
paraffin-embedded tissues. Am J Pathol. 153:1807–1812. 1998.
View Article : Google Scholar
|
|
33
|
Chen Z, Zhang K, Zhang X, et al:
Comparison of gene expression between metastatic derivatives and
their poorly metastatic parental cells implicates crucial
tumor-environment interaction in metastasis of head and neck
squamous cell carcinoma. Clin Exp Metastasis. 20:335–342. 2003.
View Article : Google Scholar
|
|
34
|
Wan HY, Guo LM, Liu T, Liu M, Li X and
Tang H: Regulation of the transcription factor NF-kappaB1 by
microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 9:162010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Garg A and Aggarwal BB: Nuclear
transcription factor-kappaB as a target for cancer drug
development. Leukemia. 16:1053–1068. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barnes CJ, Ohshiro K, Rayala SK, El-Naggar
AK and Kumar R: Insulin-like growth factor receptor as a
therapeutic target in head and neck cancer. Clin Cancer Res.
13:4291–4299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001. View Article : Google Scholar
|
|
38
|
Gibson SL, Ma Z and Shaw LM: Divergent
roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle.
6:631–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Myatt SS, Wang J, Monteiro LJ, et al:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo
T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric
cancer cells. Int J Cancer. 129:2611–2620. 2011. View Article : Google Scholar : PubMed/NCBI
|
